Author name: euretina

Masterclass #1: Diagnostic Modalities

2024, AI Diagnostic Workflow /

Masterclass #1: Diagnostic Modalities In this episode of the EURETINA AI Diagnostic Workflow Masterclass Series, Prof. Stela Vujosevic highlights the pivotal role advanced diagnostic tools play in delivering precise and effective retinal care. Explore the transformative potential of multimodal imaging in diagnosing and monitoring retinal conditions and learn how combining various modalities can enable earlier

Masterclass #1: Diagnostic Modalities Read More »

Optimizing Patient Communication Masterclasses Series – Best practices for enhancing patient education

2024, dry AMD and Geographic Atrophy /

Optimizing Patient Communication Masterclasses Series – Best practices for enhancing patient education In this EURETINA IME masterclasses series on optimizing patient communication, Dr. Jeffrey Heier shares best practices to enhance patient education for better adherence to age-related macular degeneration (AMD) treatments. He covers various patient education strategies, compares monthly versus bi-monthly injection schedules, and highlights

Optimizing Patient Communication Masterclasses Series – Best practices for enhancing patient education Read More »

Optimizing Patient Communication Masterclasses Series – Keys to patient adherence with injection therapies

2024, dry AMD and Geographic Atrophy /

Optimizing Patient Communication Masterclasses Series – Keys to patient adherence with injection therapies In this EURETINA IME masterclass series on optimizing patient communication, Dr. Patricio Schlottmann shares strategies to enhance patient compliance with age-related macular degeneration (AMD) treatments. He discusses effective in-office and out-of-clinic education, key considerations for selecting treatment schedules, the role of at-home

Optimizing Patient Communication Masterclasses Series – Keys to patient adherence with injection therapies Read More »

Future Directions

2024, Inherited Retinal Diseases /

Future Directions In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus discuss promising treatment strategies, including gene-specific targeted therapies and broader, agnostic approaches that may address multiple genes or underlying pathogenic mechanisms. They also provide an overview of ongoing cell

Future Directions Read More »

Managing IRD Patients

2024, Inherited Retinal Diseases /

Managing IRD Patients In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus underscore the importance of early detection, regular follow-ups, and referrals to specialized centers, enabling IRD patients to receive comprehensive assessments, including functional and genetic testing. They also discuss

Managing IRD Patients Read More »

Patient Communication

2024, Inherited Retinal Diseases /

Patient Communication In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black discuss key strategies for effectively communicating IRD diagnoses to patients. They address common misconceptions, clarify essential terminology, and emphasize the vital role of genetic counselors in guiding patients towards

Patient Communication Read More »

Diagnosing IRDs

2024, Inherited Retinal Diseases /

Diagnosing IRDs In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black explore the complexities of diagnosing IRDs, emphasizing the importance of a multidisciplinary approach. They discuss key diagnostic elements, challenges, and the potential of artificial intelligence to enhance diagnostic efficiency.

Diagnosing IRDs Read More »

Implementing GA Treatments

2024, dry AMD and Geographic Atrophy /

Implementing GA Treatments In this section of the EURETINA IME video interview series on dry AMD & GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore emerging complement pathway-targeting treatments for GA. They discuss key aspects, including patient selection, integrating these treatments into the GA patient workflow, and effectively communicating potential side effects. Prof.

Implementing GA Treatments Read More »

Scroll to Top